[
    {
        "id": 1,
        "position": 1,
        "startAt": "04-01-2012",
        "endAt": "04-01-2014",
        "companyName": "Humanitarian Service",
        "website": "https://www.churchofjesuschrist.org/?lang=eng",
        "logo": "assets/template/experience/logo/lds.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "Osorno",
                "country": "Chile",
                "role": "Missionary",
                "description": "Como hablante bilingüe americano de herencia latino, el idioma español y su historia han sido factores definidores en el desarrollo de mi identidad. Por consiguiente, decidí servir una misión voluntaria de tiempo completo en Patagonia en el sur de Chile. Hice servicio por más de veinte ciudades a lo largo de dos años. Por ejemplo, mantengo lazos a las ciudades de Villarrica, Valdivia, Puerto Mont, Osorno, la región de Los Lagos, and Lanco. Durante mi tiempo en Chile, llegué a querer mucho a la gente de Chile y su cultura y lo hago una prioridad para mantener las conexiones que tengo con Chile. Serví en varias posiciones de liderazgo tal como Líder de Zona, donde dirige más de veinte misioneros en la ciudad de Valdivia.<br><br>"
            },
            {
                "language": "en",
                "city": "Osorno",
                "country": "Chile",
                "role": "Missionary",
                "description": "As a bilingual American of Latino heritage, the Spanish language and history have been defining factors in the development of my identity. Consequently, I chose to serve as a full-time humanitarian missionary in Southern Chile. I volunteered in more than 20 cities over a two-year period. For example, I have ties to Villarrica, Valdivia, Puerto Mont, Osorno, the region of Los Lagos, and Lanco. During my time in Chile, I came to love the people and their culture and have made it a priority to maintain connections with those I met in Chile. I served in several positions of leadership, including Zone Leader over more than 20 missionaries in Valdivia.<br><br>"
            }
        ],
        "technologies": [
            "Spanish",
            "Leadership",
            "Finances",
            "Communication",
            "Independence",
            "Organization"
        ],
        "medias": [
            {
                "icon": "facebook",
                "title": "Facebook",
                "http": "https://www.facebook.com/ChurchofJesusChrist/"
            },
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/Ch_JesusChrist"
            },
            {
                "icon": "instagram",
                "title": "Instagram",
                "http": "https://www.instagram.com/churchofjesuschrist/"
            },
            {
                "icon": "youtube",
                "title": "Youtube",
                "http": "https://www.youtube.com/churchofjesuschrist"
            }
        ],
        "backgroundUrl": "assets/template/experience/chile.jpg"
    },
    {
        "id": 2,
        "position": 2,
        "startAt": "08-01-2014",
        "endAt": "08-01-2016",
        "companyName": "Castle Research Group",
        "website": "https://chembio.byu.edu/castle-lab",
        "logo": "assets/template/experience/logo/byu.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "Provo",
                "country": "Utah",
                "role": "Asistente de investigaciónes",
                "description": "Durante mi tiempo con el <b>Grupo de Investigaciones Castle</b>, estudié la síntesis química y el diseño de estructuralmente interesantes péptidos. Como parte de mis investigaciones, sintetizé aminoácidos artificiales y los incorporé en péptidos. La literatura es llena de una diversidad de “aminoácidos diseñadores.” Se usan estos residuos modificados para ajustar las conformaciones de la columna, cadenas laterales, y la reactividad. Uno de los residuos que creemos que merece más investigación es el aminoácido dehydro.</br></br> Péptidos que tienen aminoácidos dehydros muestran actividades potentes de antibióticos, antimicóticos, antitumorales, and fitotóxicos bioactividades. Mediante el paquete de software CYANA, calculé sus estructuras usando el NMR and calculaciones mecánicas cuánticas DFT. Mis investigaciones también se trataron de reacciones químicas y sus energéticos."
            },
            {
                "language": "en",
                "city": "Provo",
                "country": "Utah",
                "role": "Research Assistent",
                "description": "During my time at <b>BYU</b>, I studied the synthesis and design of proteolytically stable peptides. As part of my research, I synthesized non-standard amino acids and incorporated them into peptides. One type of residue that we believe merits further exploration is the dehydroamino acid. Dehydroamino acid-containing peptides exhibit potent natural antibiotic, antifungal, antitumor, and phytotoxic bioactivity. Using the computational software package CYANA, I made structural predictions using NMR and DFT-based quantum mechanics calculations.<br><br>"
            }
        ],
        "technologies": [
            "NMR",
            "DFT",
            "QM",
            "MD",
            "QM/MM",
            "CYANA",
            "Peptides",
            "Organic-Chemistry",
            "Synthesis",
            "HPC",
            "β-hairpin",
            "Python",
            "Amber",
            "Gaussian"
        ],
        "medias": [
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/castlelabbyu"
            }
        ],
        "backgroundUrl": "assets/template/experience/provo.jpg"
    },
    {
        "id": 3,
        "position": 3,
        "startAt": "05-01-2016",
        "endAt": "05-01-2018",
        "companyName": "Simmons Center for Cancer Research",
        "website": "https://sccr.byu.edu/",
        "logo": "assets/template/experience/logo/sccr.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "Provo",
                "country": "Utah",
                "role": "Becaria de Investigación",
                "description": "Como un becario de investigaciones por el <b>Simmons Centro de Investigaciones por Cancer</b>, estudiaba raros péptidos naturales con relaciones inusuales de estructura-funcion y una potencial terapéutica. Mis investigaciones se enfocaron en Yaku’amide A, un péptido extremadamente raro aislado de la mar-profunda esponja, Ceratopsian sp. Al probar contra una coleccion de 39 lineas celulares humanas, Yaku’amide A exhibió potente citotoxicidad contra de las células P388 de leucemia murina por un modo de acción potencialmente novel. Utilizando simulaciones híbridas de mecanismos quántum y mecanismos moleculares tuvimos la capacidad de estudiar sus propiedades no obstante su síntesis laboriosa que viene de su perfil de amino ácido inusual.<br><br>"
            },
            {
                "language": "en",
                "city": "Provo",
                "country": "Utah",
                "role": "Research Fellow",
                "description": "As a <b>Simmons Center for Cancer Research</b> (SCCR) fellow, I studied rare natural peptides with unusual structure-function relationships with therapeutic potential. My research focused on Yaku’amide A, an extremely rare peptide isolated from the deep-sea sponge Ceratopsion sp. When tested against an array of 39 human cancer cell lines, Yaku’amide A exhibited potent cytotoxicity against P388 murine leukemia cells via a potentially novel mode of action. Using quantum mechanics (QM)/molecular mechanic (MM) hybrid simulations we were able to study its properties despite its laborious synthesis due to its unusual amino acid profile.<br><br>"
            }
        ],
        "technologies": [
            "Cancer",
            "DFT",
            "QM",
            "MD",
            "QM/MM",
            "CYANA",
            "Peptides",
            "Organic-Chemistry",
            "Synthesis",
            "HPC",
            "Python",
            "Amber",
            "Gaussian"
        ],
        "medias": [
            {
                "icon": "facebook",
                "title": "Facebook",
                "http": "https://www.facebook.com/byusccr"
            },
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/byusccr"
            },
            {
                "icon": "instagram",
                "title": "Instagram",
                "http": "https://www.instagram.com/cougsvscancer/"
            },
            {
                "icon": "youtube",
                "title": "Youtube",
                "http": "https://www.youtube.com/channel/UCtPJlo1Z-anLx7L9zNMB9sg?app=desktop"
            },
            {
                "icon": "linkedin",
                "title": "LinkedIn",
                "http": "https://www.linkedin.com/company/byu-sccr/"
            }
        ],
        "backgroundUrl": "assets/template/experience/zions.jpg"
    },
    {
        "id": 4,
        "position": 4,
        "startAt": "04-01-2018",
        "endAt": "07-01-2018",
        "companyName": "Dana-Farber Cancer Center",
        "logo": "assets/template/experience/logo/df.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "Boston",
                "country": "MA",
                "role": "Investigador Visitante",
                "description": "Durante mi programa de práctica en El Instituto de Dana-Farber (DFCI) en el laboratorio de Dr. Arthanari, estudié la biosíntesis de los aminoácidos y los caminos metabólicos que controlan su regulación. Además, investigué los métodos novedosos de enriquecimiento isotópicos en las proteínas mediate el metabolismo de piruvato. A lo largo de la programa de práctica, aumenté mis capacidades del cultivo celular, la extracción de la proteína y su preparación, métodos de NMR y su teoría, el informático, y la reseña bibliográfica."
            },
            {
                "language": "en",
                "city": "Boston",
                "country": "MA",
                "role": "Visiting Researcher",
                "description": "During my internship at the <b>Dana-Farber Cancer Institute (DFCI)</b> in the lab of Dr. Arthanari, I studied the biosynthesis of amino acids and the metabolic pathways surrounding their regulation. Furthermore, I investigated novel methods of isotopically labeling proteins by leveraging pyruvate metabolism. During my internship, I increased my skills in cell culture, protein extraction and preparation, NMR procedures and theory, data processing, and literature curation."
            }
        ],
        "technologies": [
            "NMR",
            "Proteins",
            "Metabolomics",
            "Cell-culture",
            "Protein-purification",
            "Python"
        ],
        "medias": [
            {
                "icon": "facebook",
                "title": "Facebook",
                "http": "https://www.facebook.com/danafarbercancerinstitute"
            },
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/DanaFarber"
            },
            {
                "icon": "instagram",
                "title": "Instagram",
                "http": "https://www.instagram.com/danafarber/?hl=en"
            },
            {
                "icon": "youtube",
                "title": "Youtube",
                "http": "https://www.youtube.com/c/danafarber/"
            },
            {
                "icon": "linkedin",
                "title": "LinkedIn",
                "http": "https://www.linkedin.com/company/dana-farber-cancer-institute/"
            }
        ],
        "backgroundUrl": "assets/template/experience/boston.jpg"
    },
    {
        "id": 5,
        "position": 5,
        "startAt": "06-01-2018",
        "endAt": "10-01-2018",
        "companyName": "National Institutes of Health",
        "website": "https://irp.nih.gov/pi/nico-tjandra",
        "logo": "assets/template/experience/logo/nih.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "Bethesda",
                "country": "MD",
                "role": "Investigador Visitante",
                "description": "Durante mi tiempo hacienda investigaciones en <b>Los Institutos Nacionales de la Salud (NIH)</b> en el laboratorio de Dr. Nico Tjandra, estudié la biofísica estructural de la proteína apoptótica BCL-2 Asociado X (BAX). Mis investigaciones enfocaron en una interacción inusual con el péptido Humanin que se implica en el cáncer y el envejecimiento. Nuestras investigaciones revelaron una interacción complicaron entre BAX y Humanin que resulta en la formación de fibrillas que inhiben el camino apoptótico.<br><br>"
            },
            {
                "language": "en",
                "city": "Bethesda",
                "country": "MD",
                "role": "Visiting Researcher",
                "description": "During my internship at the <b>National Institutes of Health (NIH)</b> in the lab of Dr. Nico Tjandra, I studied conformational biophysics of the apoptotic protein called BCL-2 Associated X protein (BAX). My research focused on its unusual interaction with the small peptide Humanin implicated in cancer and aging. Our research revealed a nuanced interaction between BAX and Humanin that resulted in the formation of Humanin-based fibrils that in turn inhibited the apoptotic pathway.<br><br>"
            }
        ],
        "technologies": [
            "Biophysics",
            "Light-scattering",
            "Electron-microscopy",
            "NMR",
            "Peptides",
            "Cancer",
            "Apoptosis",
            "Aggregation",
            "Fibrilization",
            "Python"
        ],
        "medias": [
            {
                "icon": "facebook",
                "title": "Facebook",
                "http": "https://www.facebook.com/nih.gov"
            },
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/NIH"
            },
            {
                "icon": "instagram",
                "title": "Instagram",
                "http": "https://www.instagram.com/nihgov/"
            },
            {
                "icon": "youtube",
                "title": "Youtube",
                "http": "https://www.youtube.com/user/NIHOD/"
            },
            {
                "icon": "linkedin",
                "title": "LinkedIn",
                "http": "https://www.linkedin.com/company/national-institutes-of-health/"
            }
        ],
        "backgroundUrl": "assets/template/experience/bethesda.jpg"
    },
    {
        "id": 6,
        "position": 6,
        "startAt": "12-01-2018",
        "endAt": "08-01-2020",
        "companyName": "Huntsman Cancer Institute",
        "website": "https://healthcare.utah.edu/huntsmancancerinstitute/",
        "logo": "assets/template/experience/logo/hci.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "El Lago Salado",
                "country": "Utah",
                "role": "Biológico de Cancer",
                "description": "Cuando estaba en el <b>El Instituto de Cancer de Huntsman (HCI)</b>, investigué los mecanismos moleculares y la respuesta terapéutica de cáncer de pulmón microcítico (SCLC). SCLC es uno de los cánceres principales en los Estado Unidos y el mundo. Sin embargo, hay pocos tratamientos. Inicialmente, SCLC se trata con tratamientos de platino, pero no proceden una responsa duradera. Resulta en un cáncer mas agresivo. Al descubrir los mecanismos de SCLC, podemos desarrollar tratamientos individualizados para los genéticos únicos de cada tumor.<br><br>"
            },
            {
                "language": "en",
                "city": "Salt Lake City",
                "country": "Netherlands",
                "role": "Cancer Biologist",
                "description": "At the <b>Huntsman Cancer Institute (HCI)</b>, I researched the molecular mechanisms and therapeutic response and resistance of small cell lung cancer (SCLC). SCLC is a leading cause of cancer in the United States with few treatments available. Initially, SCLC is treated with platinum-based therapies; however, the response is short lived. Relapse usually occurs, resulting in even more aggressive metastatic tumors. We believe that by uncovering the mechanisms of SCLC, we can develop personalized therapeutics based on the mutations and mechanisms unique to each tumor population.<br><br>"
            }
        ],
        "technologies": [
            "Cancer",
            "Lung-cancer",
            "Small cell",
            "Squamous",
            "RNA-sequencing",
            "GSEA",
            "IHC",
            "Microscopy",
            "Pathology",
            "Network-analysis",
            "Osteosarcoma",
            "MYC"
        ],
        "medias": [
            {
                "icon": "facebook",
                "title": "Facebook",
                "http": "https://www.facebook.com/HuntsmanCancerInstitute"
            },
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/huntsmancancer"
            },
            {
                "icon": "instagram",
                "title": "Instagram",
                "http": "https://www.instagram.com/huntsmancancerinstitute/"
            },
            {
                "icon": "youtube",
                "title": "Youtube",
                "http": "https://www.youtube.com/user/huntsmancancervideos/featured"
            },
            {
                "icon": "linkedin",
                "title": "LinkedIn",
                "http": "https://www.linkedin.com/company/huntsman-cancer-institute/"
            }
        ],
        "backgroundUrl": "assets/template/experience/sl.jpg"
    },
    {
        "id": 7,
        "position": 7,
        "startAt": "09-01-2020",
        "companyName": "Massachusetts Institute of Technology",
        "website": "http://hjkgrp.mit.edu/",
        "logo": "assets/template/experience/logo/mit.svg",
        "internationalizations": [
            {
                "language": "es",
                "city": "Cambridge",
                "country": "MA",
                "role": "Engeniero biológico, Candidato de doctorado",
                "description": "El propósito general de mis investigaciones en el laboratorio <b>Kulik en MIT</b> son para aclarar los modelos principales de las relaciones entre el sustrato y la proteína en las metaloenzimas para determinar como el ambiente interno de la proteína incluye la reactividad y especificad en las enzimas que contienen hierro. Más específicamente, estudio la función del sitio activo y la proteína entero en el controlar de la reactividad de los hydroxylases y halogenases; el papel de la alosteria electrónica y el transferir de carga eléctrica el las enzimas que contienen metal.<br><br>"
            },
            {
                "language": "en",
                "city": "Cambridge",
                "country": "MA",
                "role": "Bioengineering Ph.D. Candidate",
                "description": "The overarching direction of my thesis in the <b>Kulik Lab at MIT</b> is to elucidate patterns governing substrate-protein relationships in high-valent enzymes to determine how the protein environment influences reactivity and substrate specificity in iron containing enzymes. More specifically, I study the role of the active site and greater protein environment in mediating hydroxylase vs. halogenase reactivity in non-heme iron dioxygenases; the role of electronic allostery and charge transfer in mediating reactivity in iron-containing enzymes.<br><br>"
            }
        ],
        "technologies": [
            "QM",
            "MD",
            "DFT",
            "Python",
            "QM/MM",
            "TeraChem",
            "Amber",
            "GPUs",
            "HPC",
            "ML",
            "MCPB",
            "VMD",
            "PyMol",
            "Chimera"
        ],
        "medias": [
            {
                "icon": "facebook",
                "title": "Facebook",
                "http": "https://www.facebook.com/MITnews"
            },
            {
                "icon": "twitter",
                "title": "Twitter",
                "http": "https://twitter.com/mit"
            },
            {
                "icon": "instagram",
                "title": "Instagram",
                "http": "https://www.instagram.com/mitpics/"
            },
            {
                "icon": "youtube",
                "title": "Youtube",
                "http": "https://www.youtube.com/mit"
            },
            {
                "icon": "linkedin",
                "title": "LinkedIn",
                "http": "https://www.linkedin.com/school/mit/"
            }
        ],
        "backgroundUrl": "assets/template/experience/mit.jpg"
    }
]